Humalog 100u/ml Vial 3ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty layer of the skin. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Administration Guidelines
Take the medication within 15 minutes before or immediately after a meal.
Rotate the injection site each time to avoid tissue damage.
Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
Do not use the medication if the solution appears cloudy, is leaking, or contains particles, or if the solution has changed color.
Safe Disposal and Handling
Dispose of used needles in a designated needle/sharp disposal box.
Do not reuse needles or other equipment.
When the disposal box is full, follow local regulations for proper disposal.
If you have any questions or concerns, consult your doctor or pharmacist.
Diet and Exercise
Follow the diet and exercise plan recommended by your doctor.
Be aware of the steps to take if you miss a meal or do not eat as much as usual.
Special Considerations
Do not draw the medication into a syringe and store it for future use.
Some brands of this medication may be mixed with insulin NPH, but be sure to confirm this with your doctor or pharmacist. Do not mix this medication with any other type of insulin.
If using an insulin pump, follow the doctor's instructions or the package insert for proper use. Regularly change the medication and pump parts as directed.
If the pump malfunctions, have an alternative method of insulin administration available and consult your doctor.
Storage and Disposal
Store unopened containers in the refrigerator. Do not freeze the medication, and do not use it if it has been frozen.
Missed Doses
Be aware of the procedures to follow if you miss a dose. If you are unsure, contact your doctor for guidance.
Lifestyle & Tips
- Follow your prescribed diet plan consistently.
- Engage in regular physical activity as advised by your doctor.
- Monitor your blood glucose levels frequently as instructed.
- Carry a source of fast-acting sugar (e.g., glucose tablets, juice) to treat mild to moderate hypoglycemia.
- Never share insulin pens or syringes with others, even if the needle is changed, due to risk of bloodborne pathogen transmission.
- Rotate injection sites to prevent lipodystrophy (skin changes).
Available Forms & Alternatives
Available Strengths:
- Humalog Insulin (vl-7510) 10ml
- Humalog Mix 75/25 Vial 10ml
- Humalog Cartridge 3ml
- Humalog Mix 50/50 Inj, 10ml
- Humalog Mix 50/50 Kwikpen Inj 3ml
- Humalog 100 U/ml Kwik Pen Inj 3ml
- Humalog Mix 75/25 Kwikpen Inj 3ml
- Humalog 100u/ml Vial 3ml
- Humalog 200 U/ml Kwikpen Inj 3ml
- Humalog Jr 100u/ml Kwikpnhalf Unit
- Humalog Tempo Pen 100u/ml Inj 3ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Note: In rare cases, allergic reactions can be fatal.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Local injection site reactions, including:
+ Thick skin
+ Pits or lumps
Swelling in the arms or legs
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures
If you experience any of these symptoms, contact your doctor immediately. If you have low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical help:
Weight gain
Flu-like symptoms
Nose or throat irritation
Common cold symptoms
Headache
Cough
Upset stomach
Stomach pain or diarrhea
Feeling tired or weak
* Irritation at the injection site
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, headache, blurred vision. Treat immediately with fast-acting sugar.
- Symptoms of high blood sugar (hyperglycemia): increased thirst, frequent urination, fatigue, blurred vision. Contact your doctor if persistent.
- Symptoms of allergic reaction: rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing. Seek immediate medical attention.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have low blood sugar (hypoglycemia), as this may affect your treatment plan.
This list is not exhaustive, and it is crucial to discuss all your medications, health conditions, and concerns with your doctor. Please disclose all the following to your doctor and pharmacist:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or supplements you are using
Vitamins you are taking
Any health problems you have
To ensure your safety, it is vital to verify that this medication is compatible with all your other medications and health conditions. Never start, stop, or adjust the dose of any medication without first consulting your doctor.
Precautions & Cautions
This drug may cause low blood sugar, which can lead to seizures, loss of consciousness, permanent brain damage, and even death if not properly managed. Consult your doctor to discuss the risks and prevention strategies. Additionally, this medication may cause low blood potassium levels, which can result in abnormal heart rhythms, severe breathing difficulties, and potentially death if left untreated. It is crucial to discuss this risk with your doctor.
Until you understand how this medication affects you, avoid driving and other activities that require your full attention. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure, especially when used in combination with insulin. If you are taking one of these medications, consult your doctor to discuss the potential risks.
Ensure you have the correct insulin product and understand how to properly measure and prepare your dose. Insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns, contact your doctor or pharmacist.
During periods of stress, such as illness, infection, injury, or surgery, it may be more challenging to control your blood sugar levels. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.
Wear a medical alert identification to ensure prompt care in case of an emergency. Avoid driving if you have experienced low blood sugar, as it can increase your risk of being involved in an accident.
Monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as scheduled. Consult your doctor before consuming alcohol or using products that contain alcohol.
Do not share your insulin product or any related devices, including pens, cartridge devices, needles, or syringes, with others. Sharing can lead to the transmission of infections, including those you may not be aware of having.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the potential benefits and risks to you and your baby.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (very low blood sugar)
- Confusion
- Seizures
- Loss of consciousness
- Hypokalemia (low potassium levels)
What to Do:
Seek immediate medical attention. For conscious individuals, administer oral glucose. For unconscious individuals, administer glucagon subcutaneously or intramuscularly, or intravenous glucose. Call 911 or your local emergency number. Contact Poison Control at 1-800-222-1222.
Drug Interactions
Major Interactions
- Pramlintide (increased risk of severe hypoglycemia)
- Certain atypical antipsychotics (may cause hyperglycemia, requiring increased insulin dose)
- Corticosteroids (may cause hyperglycemia, requiring increased insulin dose)
- Diuretics (thiazides, loop diuretics - may cause hyperglycemia, requiring increased insulin dose)
- Sympathomimetics (e.g., albuterol, epinephrine - may cause hyperglycemia, requiring increased insulin dose)
Moderate Interactions
- Beta-blockers (may mask symptoms of hypoglycemia, prolong recovery from hypoglycemia)
- ACE inhibitors (may enhance insulin's glucose-lowering effect)
- Angiotensin Receptor Blockers (ARBs) (may enhance insulin's glucose-lowering effect)
- Salicylates (e.g., aspirin - may enhance insulin's glucose-lowering effect)
- Sulfonamide antibiotics (may enhance insulin's glucose-lowering effect)
- Alcohol (may potentiate hypoglycemic effect, especially with fasting)
- Oral Contraceptives (may cause hyperglycemia, requiring increased insulin dose)
- Thyroid hormones (may cause hyperglycemia, requiring increased insulin dose)
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and set treatment goals.
Timing: Prior to initiation of therapy
Rationale: To establish baseline glucose levels.
Timing: Prior to initiation of therapy
Rationale: To assess kidney function, as insulin clearance may be reduced in renal impairment.
Timing: Prior to initiation of therapy
Rationale: To assess liver function, as insulin metabolism occurs in the liver.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Multiple times daily (pre-meal, post-meal, bedtime, overnight as needed)
Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL 1-2 hours post-meal
Action Threshold: Hypoglycemia (<70 mg/dL), Hyperglycemia (>180-250 mg/dL depending on target)
Frequency: Every 3-6 months (or more frequently if glycemic control is unstable)
Target: Individualized, typically <7% for most adults
Action Threshold: >7% (consider dose adjustment or therapy change)
Frequency: Daily, ongoing
Target: N/A
Action Threshold: Any symptoms (e.g., sweating, tremor, confusion, hunger, dizziness)
Symptom Monitoring
- Hypoglycemia: sweating, tremor, dizziness, confusion, hunger, irritability, headache, blurred vision, rapid heartbeat, anxiety, slurred speech, seizures, unconsciousness.
- Hyperglycemia: increased thirst, increased urination, fatigue, blurred vision, dry skin, fruity breath odor, nausea, vomiting, abdominal pain (signs of DKA).
Special Patient Groups
Pregnancy
Insulin Lispro is considered a Category B drug in pregnancy. It is the preferred treatment for glycemic control in pregnant women with diabetes (pre-existing or gestational) as it does not cross the placenta in significant amounts. Strict glycemic control is crucial to prevent adverse maternal and fetal outcomes.
Trimester-Specific Risks:
Lactation
Insulin Lispro is considered safe for use during lactation (L1). Insulin is a normal component of breast milk and is not expected to cause adverse effects in a breastfed infant. Insulin requirements may change during lactation, requiring dose adjustments.
Pediatric Use
Insulin Lispro is approved for use in pediatric patients with diabetes mellitus. Dosing must be highly individualized based on age, weight, metabolic needs, and blood glucose monitoring. Close supervision and education for parents/caregivers are essential.
Geriatric Use
Geriatric patients may be at increased risk of hypoglycemia due to age-related decline in renal function, cognitive impairment, and polypharmacy. Dosing should be initiated cautiously with careful titration and frequent blood glucose monitoring. Lower glycemic targets may be appropriate for some elderly patients to minimize hypoglycemia risk.
Clinical Information
Clinical Pearls
- Insulin Lispro should be administered within 15 minutes before a meal or immediately after a meal to optimize postprandial glucose control.
- Always check the insulin label carefully before each injection to ensure the correct type of insulin is being used.
- Rotate injection sites within the same region (e.g., abdomen) to reduce the risk of lipodystrophy.
- Patients should be educated on the signs and symptoms of hypoglycemia and how to treat it promptly.
- Never mix Humalog U-100 with other insulins in the same syringe, except for NPH insulin. If mixing, draw Humalog first.
- Vials should be stored in a refrigerator (2°C to 8°C) until first use. After first use, vials can be stored at room temperature (up to 30°C) for up to 28 days.
Alternative Therapies
- Other rapid-acting insulins: Insulin Aspart (Novolog, Fiasp), Insulin Glulisine (Apidra)
- Short-acting insulins: Regular Human Insulin (Humulin R, Novolin R)
- Intermediate-acting insulins: NPH Human Insulin (Humulin N, Novolin N)
- Long-acting insulins: Insulin Glargine (Lantus, Toujeo, Basaglar), Insulin Detemir (Levemir), Insulin Degludec (Tresiba)
- Oral antidiabetic agents (e.g., Metformin, Sulfonylureas, SGLT2 inhibitors, GLP-1 receptor agonists - often used in Type 2 diabetes, sometimes in combination with insulin)